{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:11:14Z","timestamp":1760008274970,"version":"build-2065373602"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We collected 97 cases of myeloid neoplasia with the rare cytogenetic event of isolated trisomy 19 (+19), with the aim to characterize this group clinically and pathologically. 51 patients with myelodysplastic syndrome (MDS\u2009+19) and 11 patients with myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN\u2009+19) presented with\u2009+19 at disease onset and were further analyzed. Patients with insufficient data were excluded. We collected additional clinical and laboratory data and performed mutation analysis on available bone marrow biopsies. The 62 patients of both disease groups turned out to be remarkably homogeneous in terms of male sex (85%), the presence of anemia with increased numbers of ring sideroblasts (RS, 80%), the absence of an <jats:italic>SF3B1<\/jats:italic> mutation (95%), and the overall rather consistent presence of <jats:italic>SRSF2<\/jats:italic> (61%) or <jats:italic>ASXL1<\/jats:italic> (39%) mutations. MDS\u2009+19 patients with available follow-up (1\u00a0month to 7.5\u00a0years) presented or progressed with significant fibrosis (45%), leuko- or monocytosis (13%) or acute leukemia (28%). Compared to a control cohort of 23 patients with MDS and an <jats:italic>SRSF2<\/jats:italic> mutation, but without isolated\u2009+19 (MDS-<jats:italic>SRSF2<\/jats:italic>), the 16 MDS\u2009+19 patients with <jats:italic>SRSF2<\/jats:italic> mutation and the 12 MDS\u2009+19 patients with an <jats:italic>ASXL1<\/jats:italic> mutation showed a striking difference in the presence of\u2009\u2265\u200915% RS (73% and 67% versus 17% in MDS-<jats:italic>SRSF2<\/jats:italic>) and the occurrence of fibrosis (44% and 57% versus 4% in MDS-<jats:italic>SRSF2)<\/jats:italic>. Although all individual features observed in the MDS\u2009+19 and MDS\/MPN\u2009+19 cohorts are seen in MDS and MDS\/MPN in general, their combination is rather unique and provides clues regarding disease evolution in this rare, cytogenetically defined group of myeloid neoplasia.<\/jats:p>","DOI":"10.1007\/s12308-025-00659-1","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:34:21Z","timestamp":1760006061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and\/or ASXL1 mutations"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-3302","authenticated-orcid":false,"given":"Konnie M.","family":"Hebeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3023-8916","authenticated-orcid":false,"given":"Ludmila","family":"Boudov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-4446","authenticated-orcid":false,"given":"Maarten F.","family":"Corsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2561-4717","authenticated-orcid":false,"given":"Nikola","family":"Pt\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0196-2837","authenticated-orcid":false,"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-6234","authenticated-orcid":false,"given":"Aniek O.","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-9617","authenticated-orcid":false,"given":"Jaroslav","family":"Cermak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5241-9723","authenticated-orcid":false,"given":"Tomas","family":"Vanecek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-568X","authenticated-orcid":false,"given":"Joop H.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-7430","authenticated-orcid":false,"given":"Marian J. P. L.","family":"Stevens-Kroef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-1742","authenticated-orcid":false,"given":"Leonie I.","family":"Kroeze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"1","key":"659_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0165-4608(94)90031-0","volume":"74","author":"B Johansson","year":"1994","unstructured":"Johansson B, Billstr\u00f6m R, Mauritzson N, Mitelman F (1994) Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms. Cancer Genet Cytogenet 74(1):62\u201365. https:\/\/doi.org\/10.1016\/0165-4608(94)90031-0","journal-title":"Cancer Genet Cytogenet"},{"key":"659_CR2","doi-asserted-by":"publisher","unstructured":"Espersen ADL, Noren-Nystr\u00f6m U, Abrahamsson J, Ha SY, Pronk CJ. Jahnukainen K et al (2018) AML with t (7; 12)(q36; p13) is associated with infancy and trisomy 19. Data from NOPHO-AML and review of the literature.\u00a0Genes, Chromosomes & Cancer,\u00a057(7): 359\u2013365. https:\/\/doi.org\/10.1002\/gcc.22538","DOI":"10.1002\/gcc.22538"},{"issue":"8","key":"659_CR3","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3324\/haematol.2022.282127","volume":"108","author":"S Kayser","year":"2023","unstructured":"Kayser S, Mart\u00ednez-Cuadr\u00f3n D, Rodriguez-Veiga R, H\u00e4nel M, Tormo M, Sch\u00e4fer-Eckart K et al (2023) Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia. Haematologica 108(8):2059\u20132066. https:\/\/doi.org\/10.3324\/haematol.2022.282127","journal-title":"Haematologica"},{"issue":"3","key":"659_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/gcc.1192","volume":"32","author":"S Alvarez","year":"2001","unstructured":"Alvarez S, MacGrogan D, Calasanz MJ, Nimer SD, Jhanwar SC (2001) Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization. Genes Chromosomes Cancer 32(3):285\u2013293. https:\/\/doi.org\/10.1002\/gcc.1192","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"659_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","volume":"30","author":"J Schanz","year":"2012","unstructured":"Schanz J, T\u00fcchler H, Sol\u00e9 F, Mallo M, Lu\u00f1o E, Cervera J et al (2012) New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 30(8):820\u2013829. https:\/\/doi.org\/10.1200\/JCO.2011.35.6394","journal-title":"J Clin Oncol"},{"issue":"8","key":"659_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.leukres.2006.01.003","volume":"30","author":"M Daskalakis","year":"2006","unstructured":"Daskalakis M, Mauritzson N, Johansson B, Bouabdallah K, Onida F, Kunzmann R et al (2006) Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia. Leuk Res 30(8):1043\u20131047. https:\/\/doi.org\/10.1016\/j.leukres.2006.01.003","journal-title":"Leuk Res"},{"issue":"3","key":"659_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3):354\u2013365. https:\/\/doi.org\/10.1182\/blood-2009-11-254441","journal-title":"Blood"},{"issue":"12","key":"659_CR8","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F et al (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454\u20132465. https:\/\/doi.org\/10.1182\/blood-2012-03-420489","journal-title":"Blood"},{"issue":"6","key":"659_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ccell.2023.04.006","volume":"41","author":"IA van Zeventer","year":"2023","unstructured":"van Zeventer IA, de Graaf AO, Salzbrunn JB, Nolte IM, Kamphuis P, Dinmohamed A et al (2023) Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. Cancer Cell 41(6):1017-1031.e4. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.006","journal-title":"Cancer Cell"},{"key":"659_CR10","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36:1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"issue":"11","key":"659_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"issue":"30","key":"659_CR12","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","volume":"23","author":"L Malcovati","year":"2005","unstructured":"Malcovati L, Porta MGD, Pascutto C, Invernizzi R, Boni M, Travaglino E et al (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 23(30):7594\u20137603. https:\/\/doi.org\/10.1200\/JCO.2005.01.7038","journal-title":"J Clin Oncol"},{"key":"659_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41375-022-01783-y","volume":"37","author":"S Huber","year":"2023","unstructured":"Huber S, Haferlach T, Meggendorfer M, Hutter S, Hoermann G, Summerer I et al (2023) Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. Leukemia 37:500\u2013502. https:\/\/doi.org\/10.1038\/s41375-022-01783-y","journal-title":"Leukemia"},{"issue":"15","key":"659_CR14","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1182\/blood-2012-02-412296","volume":"120","author":"SJ Wu","year":"2012","unstructured":"Wu SJ, Kuo YY, Hou HA, Li LY, Tseng MH, Huang CF et al (2012) The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution. Blood 120(15):3106\u20133111. https:\/\/doi.org\/10.1182\/blood-2012-02-412296","journal-title":"Blood"},{"key":"659_CR15","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41375-023-01899-9","volume":"37","author":"S Urrutia","year":"2023","unstructured":"Urrutia S, Li Z, Almanza E, Bataller A, Kanagal-Shamanna R, Senapati J et al (2023) Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia 37:1397\u20131400. https:\/\/doi.org\/10.1038\/s41375-023-01899-9","journal-title":"Leukemia"},{"issue":"22","key":"659_CR16","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al (2013) Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122(22):3616\u20133627. https:\/\/doi.org\/10.1182\/blood-2013-08-518886","journal-title":"Blood"},{"issue":"12","key":"659_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0145-2126(00)00088-6","volume":"24","author":"U Germing","year":"2000","unstructured":"Germing U, Gattermann N, Strupp C, Aivado M et al (2000) Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24(12):983\u2013992. https:\/\/doi.org\/10.1016\/s0145-2126(00)00088-6","journal-title":"Leuk Res"},{"issue":"24","key":"659_CR18","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","volume":"118","author":"L Malcovati","year":"2011","unstructured":"Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C et al (2011) Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms. Blood 118(24):6239\u20136246. https:\/\/doi.org\/10.1182\/blood-2011-09-377275","journal-title":"Blood"},{"issue":"5","key":"659_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","volume":"27","author":"MG Della Porta","year":"2009","unstructured":"Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C et al (2009) Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol 27(5):754\u2013762. https:\/\/doi.org\/10.1200\/JCO.2008.18.2246","journal-title":"J Clin Oncol"},{"issue":"13","key":"659_CR20","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","volume":"110","author":"D Haase","year":"2007","unstructured":"Haase D, Germing U, Schanz J, Pfeilst\u00f6cker M, N\u00f6sslinger T, Hildebrandt B et al (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110(13):4385\u20134395. https:\/\/doi.org\/10.1182\/blood-2007-03-082404","journal-title":"Blood"},{"key":"659_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.leukres.2017.02.008","volume":"57","author":"C Strupp","year":"2017","unstructured":"Strupp C, Nachtkamp K, Hildebrandt B, Giagounidis A, Haas R, Gattermann N et al (2017) New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): characteristics of refined MDS types. Leuk Res 57:78\u201384. https:\/\/doi.org\/10.1016\/j.leukres.2017.02.008","journal-title":"Leuk Res"},{"issue":"1","key":"659_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70073","volume":"9","author":"D Rombaut","year":"2025","unstructured":"Rombaut D, Sandmann S, Tekath T, Crouch S, de Graaf AO, Smith A et al (2025) Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes. HemaSphere 9(1):e70073. https:\/\/doi.org\/10.1002\/hem3.70073","journal-title":"HemaSphere"},{"key":"659_CR23","doi-asserted-by":"publisher","unstructured":"Jiang L, Wang L, Shen C, Zhu S, Lang W, Luo Y et al (2022) Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03905-y","DOI":"10.1007\/s00432-021-03905-y"},{"issue":"10","key":"659_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa2024534","volume":"384","author":"EJ Duncavage","year":"2021","unstructured":"Duncavage EJ, Schroeder MC, O\u2019Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S et al (2021) Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers. N Engl J Med 384(10):924\u2013935. https:\/\/doi.org\/10.1056\/NEJMoa2024534","journal-title":"N Engl J Med"},{"issue":"11","key":"659_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cancergen.2011.10.004","volume":"204","author":"KA Kolquist","year":"2011","unstructured":"Kolquist KA, Schultz RA, Furrow A, Brown TC, Han JY, Campbell LJ et al (2011) Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes. Cancer Genet 204(11):603\u2013628","journal-title":"Cancer Genet"},{"issue":"1","key":"659_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0165-4608(88)90048-9","volume":"33","author":"J Musilova","year":"1988","unstructured":"Musilova J, Michalova K (1988) Chromosome study of 85 patients with myelodysplastic syndrome. Cancer Genet Cytogenet 33(1):39\u201350. https:\/\/doi.org\/10.1016\/0165-4608(88)90048-9","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"659_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1309\/FU04-P779-U310-R3EE","volume":"126","author":"SA Wang","year":"2006","unstructured":"Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J et al (2006) Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Am J Clin Pathol 126(5):789\u2013797. https:\/\/doi.org\/10.1309\/FU04-P779-U310-R3EE","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"659_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0165-4608(93)90052-n","volume":"65","author":"AM Mansoor","year":"1993","unstructured":"Mansoor AM, Bharadwaj TP, Sethuraman S, Chandy M, Pushpa V, Kamada N, Murthy PB (1993) Analysis of karyotype, SCE, and point mutation of RAS oncogene in Indian MDS patients. Cancer Genet Cytogenet 65(1):12\u201320. https:\/\/doi.org\/10.1016\/0165-4608(93)90052-n","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"659_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1601-5223.1984.tb00444.x","volume":"101","author":"S Knuutila","year":"1984","unstructured":"Knuutila S, Teerenhovi L, Borgstr\u00f6m GH (1984) Chromosome instability is associated with hypodiploid clones in myelodysplastic syndromes. Hereditas 101(1):19\u201330. https:\/\/doi.org\/10.1111\/j.1601-5223.1984.tb00444.x","journal-title":"Hereditas"},{"issue":"1","key":"659_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0165-4608(92)90315-y","volume":"64","author":"F Sol\u00e9","year":"1992","unstructured":"Sol\u00e9 F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR et al (1992) Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 64(1):12\u201320. https:\/\/doi.org\/10.1016\/0165-4608(92)90315-y","journal-title":"Cancer Genet Cytogenet"},{"issue":"12","key":"659_CR31","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1002\/cncr.23977","volume":"113","author":"O Pozdnyakova","year":"2008","unstructured":"Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA (2008) Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer 113(12):3331\u20133340. https:\/\/doi.org\/10.1002\/cncr.23977","journal-title":"Cancer"},{"issue":"1","key":"659_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF01607138","volume":"421","author":"M Werner","year":"1992","unstructured":"Werner M, Maschek H, Kaloutsi V, Choritz H, Georgii A (1992) Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance. Virchows Arch 421(1):47\u201352. https:\/\/doi.org\/10.1007\/BF01607138","journal-title":"Virchows Arch"},{"key":"659_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-4","volume":"5","author":"Y Sugimoto","year":"2012","unstructured":"Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A et al (2012) Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. J Hematol Oncol 5:4. https:\/\/doi.org\/10.1186\/1756-8722-5-4","journal-title":"J Hematol Oncol"},{"issue":"2","key":"659_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0165-4608(90)90045-c","volume":"44","author":"JE Humphries","year":"1990","unstructured":"Humphries JE, Wheby MS (1990) Trisomy 19 in a patient with myelodysplastic syndrome and thrombocytosis. Cancer Genet Cytogenet 44(2):187\u2013191. https:\/\/doi.org\/10.1016\/0165-4608(90)90045-c","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"659_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3343\/kjlm.2008.28.3.174","volume":"28","author":"SI Jung","year":"2008","unstructured":"Jung SI, Cho HS, Lee CH, Kim KD, Ha JO, Kim MK et al (2008) Two cases of trisomy 19 as a sole chromosomal abnormality in myeloid disorders. Korean J Lab Med 28(3):174\u2013178. https:\/\/doi.org\/10.3343\/kjlm.2008.28.3.174","journal-title":"Korean J Lab Med"},{"issue":"9","key":"659_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0145-2126(92)90030-B","volume":"16","author":"United Kingdom Cancer Cytogenetics Group (UKCCG)","year":"1992","unstructured":"United Kingdom Cancer Cytogenetics Group (UKCCG) (1992) Primary, single, autosomal trisomies associated with haematological disorders. Leuk Res 16(9):841\u2013851. https:\/\/doi.org\/10.1016\/0145-2126(92)90030-B","journal-title":"Leuk Res"},{"issue":"3","key":"659_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1046\/j.1365-2141.1996.d01-1692.x","volume":"93","author":"K van Lom","year":"1996","unstructured":"van Lom K, Hagemeijer A, Vandekerckhove F, Smit EM, L\u00f6wenberg B (1996) Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol 93(3):594\u2013600. https:\/\/doi.org\/10.1046\/j.1365-2141.1996.d01-1692.x","journal-title":"Br J Haematol"},{"key":"659_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00580-011-1298-0","volume":"21","author":"K Muhyieddeen","year":"2012","unstructured":"Muhyieddeen K, Natelson EA (2012) Atypical ringed sideroblasts in association with trisomy 19 and myelodysplasia. Comp Clin Pathol 21:223\u2013225. https:\/\/doi.org\/10.1007\/s00580-011-1298-0","journal-title":"Comp Clin Pathol"},{"issue":"9","key":"659_CR39","first-page":"632","volume":"24","author":"A Rashid","year":"2014","unstructured":"Rashid A, Khurshid M, Shaikh U, Adil S (2014) Chromosomal abnormalities in primary myelodysplastic syndrome. JCPSP J Coll Physicians Surg Pak 24(9):632","journal-title":"JCPSP J Coll Physicians Surg Pak"},{"issue":"12","key":"659_CR40","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/1097-0142(19821215)50:12<2834::aid-cncr2820501224>3.0.co;2-h","volume":"50","author":"N Kardon","year":"1982","unstructured":"Kardon N, Schulman P, Degnan TJ, Budman DR, Davis J, Vinciguerra V (1982) Cytogenetic findings in the dysmyelopoietic syndrome. Cancer 50(12):2834\u20132838. https:\/\/doi.org\/10.1002\/1097-0142(19821215)50:12%3c2834::aid-cncr2820501224%3e3.0.co;2-h","journal-title":"Cancer"},{"issue":"16","key":"659_CR41","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood.2019004229","volume":"136","author":"L Palomo","year":"2020","unstructured":"Palomo L, Meggendorfer M, Hutter S, Twardziok S, Adem\u00e0 V, Fuhrmann I et al (2020) Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms. Blood 136(16):1851\u20131862. https:\/\/doi.org\/10.1182\/blood.2019004229","journal-title":"Blood"},{"issue":"2","key":"659_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00622-8","volume":"12","author":"AA Mangaonkar","year":"2022","unstructured":"Mangaonkar AA, Lasho TL, Ketterling RP, Reichard KK, Gangat N, Al-Kali A et al (2022) Myelodysplastic\/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS\/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood Cancer J 12(2):26. https:\/\/doi.org\/10.1038\/s41408-022-00622-8","journal-title":"Blood Cancer J"},{"issue":"20","key":"659_CR43","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1158\/1078-0432.CCR-23-0538","volume":"29","author":"G Todisco","year":"2023","unstructured":"Todisco G, Creignou M, Bernard E, Bj\u00f6rklund AC, Moura PL, Tesi B et al (2023) Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts. Clin Cancer Res 29(20):4256\u20134267. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0538","journal-title":"Clin Cancer Res"},{"key":"659_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2352-3026(22)00323-4","volume":"136","author":"G Maggioni","year":"2020","unstructured":"Maggioni G, Travaglino E, Pierola AA, Kaivers J, Arnan M, Meggendorfer M et al (2020) A sex-informed approach to improve prognostication and personalized decision-making process in myelodysplastic syndromes. A European study of 11.878 patients. Blood 136:23\u201324. https:\/\/doi.org\/10.1016\/S2352-3026(22)00323-4","journal-title":"Blood"},{"issue":"2","key":"659_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","volume":"126","author":"L Malcovati","year":"2015","unstructured":"Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, J\u00e4dersten M, Jansson M et al (2015) SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 126(2):233\u2013241. https:\/\/doi.org\/10.1182\/blood-2015-03-633537","journal-title":"Blood"},{"issue":"2","key":"659_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/blood-2011-09-377994","volume":"119","author":"MM Patnaik","year":"2012","unstructured":"Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G et al (2012) SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. Blood 119(2):569\u2013572. https:\/\/doi.org\/10.1182\/blood-2011-09-377994","journal-title":"Blood"},{"issue":"4","key":"659_CR47","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3390\/curroncol31040134","volume":"31","author":"S Mortuza","year":"2024","unstructured":"Mortuza S, Chin-Yee B, James TE, Chin-Yee IH, Hedley BD, Ho JM et al (2024) Myelodysplastic neoplasms (MDS) with ring sideroblasts or SF3B1 mutations: the improved clinical utility of World Health Organization and International Consensus Classification 2022 definitions, a single-centre retrospective chart review. Curr Oncol 31(4):1762\u20131773. https:\/\/doi.org\/10.3390\/curroncol31040134","journal-title":"Curr Oncol"},{"issue":"15","key":"659_CR48","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365(15):1384\u20131395. https:\/\/doi.org\/10.1056\/NEJMoa1103283","journal-title":"N Engl J Med"},{"issue":"3","key":"659_CR49","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/ijlh.13400","volume":"43","author":"JL Patel","year":"2021","unstructured":"Patel JL, Abedi M, Cogle CR, Erba HP, Foucar K, Garcia-Manero G et al (2021) Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes. Int J Lab Hematol 43(3):426\u2013432. https:\/\/doi.org\/10.1111\/ijlh.13400","journal-title":"Int J Lab Hematol"},{"key":"659_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3343\/alm.2022.42.3.299","volume":"42","author":"AG Jain","year":"2022","unstructured":"Jain AG, Zhang L, Bennett JM, Komrokji R (2022) Myelodysplastic syndromes with bone marrow fibrosis: an update. Ann Lab Med 42:299\u2013305. https:\/\/doi.org\/10.3343\/alm.2022.42.3.299","journal-title":"Ann Lab Med"},{"issue":"4","key":"659_CR51","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3390\/cancers7040903","volume":"7","author":"A Stelling","year":"2015","unstructured":"Stelling A, Jonas BA, Rashidi HH, Abedi M, Chen M (2015) Acute myeloid leukemia with isolated trisomy 19 associated with diffuse myelofibrosis and osteosclerosis. Cancers (Basel) 7(4):2459\u20132465. https:\/\/doi.org\/10.3390\/cancers7040903","journal-title":"Cancers (Basel)"},{"issue":"3","key":"659_CR52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.leukres.2004.08.004","volume":"29","author":"F L\u00e4nger","year":"2005","unstructured":"L\u00e4nger F, Dingemann J, Kreipe H, Lehmann U (2005) Up-regulation of DNA methyltransferases DNMT1, 3A, and 3B in myelodysplastic syndrome. Leuk Res 29(3):325\u2013329. https:\/\/doi.org\/10.1016\/j.leukres.2004.08.004","journal-title":"Leuk Res"},{"issue":"9","key":"659_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091562","volume":"13","author":"JJ Rodriguez-Sevilla","year":"2022","unstructured":"Rodriguez-Sevilla JJ, Calvo X, Arenillas L (2022) Causes and pathophysiology of acquired sideroblastic anemia. Genes 13(9):1562. https:\/\/doi.org\/10.3390\/genes13091562","journal-title":"Genes"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00659-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:34:22Z","timestamp":1760006062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00659-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["659"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00659-1","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study has obtained IRB approval from the Radboudumc Medical Ethical Committee (CMO 2019\u20135503) and the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial interests"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"45"}}